Heritable human genome editing: the National Academies/Royal Society report
By Peter Mills,
Nuffield Council on Bioethics
| 09. 08. 2020
The Consensus Study Report of the International Commission on the Clinical Use of Human Germline Genome Editing convened by the US National Academies of Medicine and Sciences and the UK’s Royal Society was published on 3 September.
Heritable human genome editing is a substantial report and stands as a worthy contribution to discussion of heritable human genome editing (HHGE) in the English-speaking world alongside the National Academies’ earlier (and broader) report, Human Genome Editing, science, ethics, and governance (2017) and our own Nuffield Council report, Genome editing and human reproduction: social and ethical issues (2018).
There are many good things about this report. It is clear, thoughtful and detailed. The Commission has bent itself earnestly to fulfilling the task given to it by the commissioning academies. The coverage of the current state of the science, the prospects for the use of HHGE in the clinic, and the presentation of its potential applications manages to be both thorough and readable. It strives constantly to keep its feet on the ground, both through repeated reference to the technical uncertainties that should still...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...